- Fellowship: University of Nebraska (Rheumatology)
- Residency: Creighton University (Internal Medicine )
- Residency: LNR Foundation School (General Practice )
- Residency: Delhi University (Dermatology )
- Bachelor's Degree: Maulana Azad Medical College (Medicine and Surgery)
American Board of Internal Medicine (Rheumatology) (Certification Date: 2016-10-13)
American Board of Internal Medicine (Certification Date: 2012-08-15) - (Recertification Date: 2024-02-10)
Internal Medicine
Rheumatology
- Medical Sciences Building
- Email vashispa@ucmail.uc.edu
Clinical Interests
Internal Medicine
Ankylosing Spondylitis
Autoimmune Vasculitis
Behcet Syndrome (Neuro-Bechet)
Central Nervous System Lupus Vasculitis
Collagen Disease
CREST Syndrome
Cryoglobulinemia
Cutaneous, Leukocytoclastic, Vasculitis
Gout
Hip Rheumatoid Arthritis
Lupus (Systemic lupus erythematosus)
Lupus Erythematosus Panniculitis
Lupus Nephritis
Microscopic Polyangiitis
Mixed Connective Tissue Disease (MCTD)
Osteochondritis Dissecans
Overlap Connective Tissue Disease
Paget Disease
Polymyalgia Rheumatica
Polymyositis
Polymyositis/Dermatomyositis
Pseudogout
Psoriatic Arthritis
Raynaud Phenomenon in Scleroderma
Raynaud's Disease
Reactive Arthritis (Reiter's Syndrome)
Rheumatoid Arthritis
Rheumatoid Vasculitis
Still's Disease
Systemic Lupus Erythematosus (SLE)
Systemic Vasculitis
Takayasu Arteritis
Temporal Arteritis (Giant cell arteritis)
Vasculitis (Angiitis)
Weill-Marchesani Syndrome
Peer Reviewed Publications
Onuorah, Nneoma; Abraham, Hrudya; Vashisht, Priyanka 2020. The Diagnostic Conundrum of Felty Syndrome and T-Cell Large Granular Lymphocytic Leukemia. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, ,
Vashisht, Priyanka; O'dell, James 2017. Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences. Expert opinion on biological therapy, 17 8, 989-999
Vashisht P.;Sayles H.;Cannella A.;Mikuls T.;Michaud K. 10-01-2016. Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials Arthritis Care and Research, 68 10, 1478-1488
Wampler Muskardin T.;Vashisht P.;Dorschner J.M.;Jensen M.A.;Chrabot B.S.;Kern M.;Curtis J.R.;Danila M.I.;Cofield S.S.;Shadick N.;Nigrovic P.A.;St Clair E.W.;Bingham C.O.;Furie R.;Robinson W.;Genovese M.;Striebich C.C.;O'Dell J.R.;Thiele G.M.;Moreland L.W.;Levesque M.;Bridges S.L.;Gregersen P.K.;Niewold T.B. 10-01-2016. Increased pretreatment serum IFN-?/? ratio predicts non-response to tumour necrosis factor ? inhibit Annals of the rheumatic diseases, 75 10, 1757-1762
Vashisht P.;Borghoff K.;O'Dell J.;Hearth-Holmes M. 07-01-2017. Belimumab for the treatment of recalcitrant cutaneous lupus Lupus, 26 8, 857-864
Vashisht P.;Casale T. 01-01-2013. Omalizumab for treatment of allergic rhinitis Expert Opinion on Biological Therapy, 13 6, 933-945